Isatuximab short duration fixed volume infusion combination therapy for relapsed/refractory multiple myeloma (RRMM): phase 1b feasibility/safety study
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2019）
关键词
CD38,monoclonal antibody,Multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要